The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A real-world comparison of trifluridine/tipiracil and regorafenib in refractory metastatic colorectal cancer in the United States.
 
Christopher Duane Nevala-Plagemann
No Relationships to Disclose
 
Jian Ying
No Relationships to Disclose
 
Shashank Sama
No Relationships to Disclose
 
Vaia Florou
No Relationships to Disclose
 
Benjamin Haaland
Consulting or Advisory Role - AstraZeneca; National Kidney Foundation; Prometic Life Sciences; Value Analytics Labs
Travel, Accommodations, Expenses - Flatiron Health
 
Ignacio Garrido-Laguna
Consulting or Advisory Role - Array BioPharma; Eisai
Research Funding - ARMO BioSciences (Inst); Bayer (Inst); BridgeBio Pharma (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Ignyta (Inst); Incyte (Inst); Jacobio (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Pfizer (Inst); Tolero Pharmaceuticals (Inst)